Adagene's Series B Round

Adagene raised a round of funding on January 28, 2016.

Adagene (天演药业) is a biotechnology company focused on the discovery and development of antibody therapeutics for partner companies and for its own internal pipeline. Adagene's vision is to vast…

Articles about Adagene's Series B Round: